Scope of Work
Describe the study-specific activities, enrollment targets, responsibilities of sponsor, CRO, and site, including ancillary services, timelines, deliverables, and any deviations from the master clinical trial agreement.
A Healthcare Clinical Trial Addendum reduces ambiguity by allocating regulatory responsibilities, specifying data privacy and HIPAA safeguards, and defining reporting and monitoring duties. Clear addenda lower legal risk, speed institutional approvals, and help ensure participant protections are consistently applied across sponsor, CRO, and site relationships.
Sponsors, clinical research organizations, investigative sites, and institutional legal or compliance departments typically prepare and execute these addenda.
Institutional review boards, data privacy officers, and external counsel commonly review final language prior to signature and site activation.
Describe the study-specific activities, enrollment targets, responsibilities of sponsor, CRO, and site, including ancillary services, timelines, deliverables, and any deviations from the master clinical trial agreement.
Specify protected health information handling, permitted uses and disclosures, de-identification methods, security controls, and any Business Associate Agreement requirements to satisfy HIPAA and institutional policies.
Define adverse event reporting timelines, responsible parties for expedited reports, serious adverse event escalation procedures, and requirements for notification to IRBs and regulatory agencies.
Allocate ownership and publication rights for trial data and inventions, describe prepublication review periods, redaction for confidential information, and post-trial data sharing conditions.
Set indemnification scope, insurance minimums, limitation of liability clauses, allocation of negligence, and responsibilities for third-party claims arising from trial conduct.
State procedures for amending the addendum, required approvals, effective dates for changes, and termination rights tied to regulatory actions or enrollment failures.
| Field | Configuration |
|---|---|
| Template Name | Master addendum template with variables |
| Authentication | Email + SMS code or SSO where required |
| Routing Order | Sponsor → CRO → Site sequential signing |
| Retention Policy | Auto-archive for retention period with audit trail |
Use an eSignature platform that supports HIPAA, audit trails, and common file formats (PDF, DOCX) for secure execution.
IRB must approve consent and addendum before participant enrollment.
Report serious adverse events per FDA timelines, typically within 24–48 hours.
Addendum takes effect on the date signed by all parties.
Notify sponsor and IRB promptly as required by agreement.
Maintain records per HIPAA and sponsor retention policies.
Parties exchange proposed language and resolve issues.
Counsel and IRB verify compliance and consent alignment.
Authorized representatives sign and date the addendum.
Distribute executed copies and update trial documentation.
An academic medical center used an addendum to standardize vendor data access across multiple departments and harmonize IRB-required consent language for a multicenter oncology study.
A community research site added specific payment schedules and monitoring windows to the addendum to align sponsor reimbursements with local staffing constraints.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Trial available | Trial available | Trial available | Trial available |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |